GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » EV-to-EBIT

Electromedical Technologies (Electromedical Technologies) EV-to-EBIT : -1.50 (As of May. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Electromedical Technologies's Enterprise Value is $2.63 Mil. Electromedical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.75 Mil. Therefore, Electromedical Technologies's EV-to-EBIT for today is -1.50.

The historical rank and industry rank for Electromedical Technologies's EV-to-EBIT or its related term are showing as below:

EMED' s EV-to-EBIT Range Over the Past 10 Years
Min: -22.73   Med: -1.31   Max: -0.69
Current: -1.52

During the past 5 years, the highest EV-to-EBIT of Electromedical Technologies was -0.69. The lowest was -22.73. And the median was -1.31.

EMED's EV-to-EBIT is ranked worse than
100% of 455 companies
in the Medical Devices & Instruments industry
Industry Median: 20.82 vs EMED: -1.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Electromedical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $2.70 Mil. Electromedical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.75 Mil. Electromedical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -64.76%.


Electromedical Technologies EV-to-EBIT Historical Data

The historical data trend for Electromedical Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies EV-to-EBIT Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
-26.84 -3.10 -1.43 -1.21 -1.54

Electromedical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.21 -1.40 -0.87 -1.33 -1.54

Competitive Comparison of Electromedical Technologies's EV-to-EBIT

For the Medical Devices subindustry, Electromedical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromedical Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's EV-to-EBIT falls into.



Electromedical Technologies EV-to-EBIT Calculation

Electromedical Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.629/-1.748
=-1.50

Electromedical Technologies's current Enterprise Value is $2.63 Mil.
Electromedical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Electromedical Technologies  (OTCPK:EMED) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Electromedical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1.748/2.6993002
=-64.76 %

Electromedical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $2.70 Mil.
Electromedical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Electromedical Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromedical Technologies (Electromedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260
Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.
Executives
Hymers Iii R. Leslie director 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson director PO BOX 41828, MESA AZ 41828
Donald J Steinberg 10 percent owner 3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson director, officer: CEO, CFO 16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260

Electromedical Technologies (Electromedical Technologies) Headlines

From GuruFocus